Modelling the clonal evolution of Burkitt lymphoma using patient-derived xenografts

S. Chang; H. Blair; N. Bell; S. Nakjang; C. Steel; A. Iliasova; M. Zaka; M. Singh; F. Vogiatzi; K. Frith; M. Bashton; J. Loeffen; D. Schewe; O. Heidenreich; J. Vormoor; V. Rand; C. Bacon; S. Bomken

doi:10.1016/S0145-2126(22)00273-9

Modelling the clonal evolution of Burkitt lymphoma using patient-derived xenografts

S. Chang, H. Blair, N. Bell, S. Nakjang, C. Steel, A. Iliasova, M. Zaka, M. Singh, F. Vogiatzi, K. Frith, M. Bashton, J. Loeffen, D. Schewe, O. Heidenreich, J. Vormoor, V. Rand, C. Bacon, S. Bomken

Applied Sciences Department

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Article number	079
Pages (from-to)	S51-S51
Number of pages	1
Journal	Leukemia Research
Volume	121
Issue number	Supplement
Early online date	20 Oct 2022
DOIs	https://doi.org/10.1016/S0145-2126(22)00273-9
Publication status	Published - Oct 2022
Event	Seventh International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma - The Intercontinental, New York, United States Duration: 20 Oct 2022 → 23 Oct 2022 https://cayanhl.pcrf-kids.org/

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0145-2126(22)00273-9

Cite this

Chang, S., Blair, H., Bell, N., Nakjang, S., Steel, C., Iliasova, A., Zaka, M., Singh, M., Vogiatzi, F., Frith, K., Bashton, M., Loeffen, J., Schewe, D., Heidenreich, O., Vormoor, J., Rand, V., Bacon, C., & Bomken, S. (2022). Modelling the clonal evolution of Burkitt lymphoma using patient-derived xenografts. Leukemia Research, 121(Supplement), S51-S51. Article 079. https://doi.org/10.1016/S0145-2126(22)00273-9

@article{fa503b16234344dd98e9083104b78c61,

title = "Modelling the clonal evolution of Burkitt lymphoma using patient-derived xenografts",

author = "S. Chang and H. Blair and N. Bell and S. Nakjang and C. Steel and A. Iliasova and M. Zaka and M. Singh and F. Vogiatzi and K. Frith and M. Bashton and J. Loeffen and D. Schewe and O. Heidenreich and J. Vormoor and V. Rand and C. Bacon and S. Bomken",

note = "Funding information: Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Number R13CA275201.; Seventh International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma ; Conference date: 20-10-2022 Through 23-10-2022",

year = "2022",

month = oct,

doi = "10.1016/S0145-2126(22)00273-9",

language = "English",

volume = "121",

pages = "S51--S51",

journal = "Leukemia Research",

issn = "0145-2126",

publisher = "Elsevier",

number = "Supplement",

url = "https://cayanhl.pcrf-kids.org/",

}

Chang, S, Blair, H, Bell, N, Nakjang, S, Steel, C, Iliasova, A, Zaka, M, Singh, M, Vogiatzi, F, Frith, K, Bashton, M, Loeffen, J, Schewe, D, Heidenreich, O, Vormoor, J, Rand, V, Bacon, C & Bomken, S 2022, 'Modelling the clonal evolution of Burkitt lymphoma using patient-derived xenografts', Leukemia Research, vol. 121, no. Supplement, 079, pp. S51-S51. https://doi.org/10.1016/S0145-2126(22)00273-9

TY - JOUR

T1 - Modelling the clonal evolution of Burkitt lymphoma using patient-derived xenografts

AU - Chang, S.

AU - Blair, H.

AU - Bell, N.

AU - Nakjang, S.

AU - Steel, C.

AU - Iliasova, A.

AU - Zaka, M.

AU - Singh, M.

AU - Vogiatzi, F.

AU - Frith, K.

AU - Bashton, M.

AU - Loeffen, J.

AU - Schewe, D.

AU - Heidenreich, O.

AU - Vormoor, J.

AU - Rand, V.

AU - Bacon, C.

AU - Bomken, S.

N1 - Funding information: Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Number R13CA275201.

PY - 2022/10

Y1 - 2022/10

U2 - 10.1016/S0145-2126(22)00273-9

DO - 10.1016/S0145-2126(22)00273-9

M3 - Meeting Abstract

SN - 0145-2126

VL - 121

SP - S51-S51

JO - Leukemia Research

JF - Leukemia Research

IS - Supplement

M1 - 079

T2 - Seventh International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma

Y2 - 20 October 2022 through 23 October 2022

ER -